Sotera Health (NASDAQ:SHC) Sees Strong Trading Volume – Here’s Why

Sotera Health Company (NASDAQ:SHC) shares saw unusually-strong trading volume on Thursday . Approximately 3,362,101 shares traded hands during trading, an increase of 92% from the previous session’s volume of 1,754,847 shares.The stock last traded at $15.21 and had previously closed at $15.76.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. Citigroup upped their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. William Blair began coverage on shares of Sotera Health in a research report on Thursday, December 18th. They set an “outperform” rating for the company. Royal Bank Of Canada began coverage on shares of Sotera Health in a research note on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price target on the stock. Finally, Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Sotera Health has an average rating of “Moderate Buy” and an average target price of $20.43.

Sotera Health Stock Down 4.1%

The firm has a market cap of $4.30 billion, a PE ratio of 56.00 and a beta of 1.84. The company has a quick ratio of 2.24, a current ratio of 2.46 and a debt-to-equity ratio of 3.66. The business has a 50-day moving average price of $17.84 and a two-hundred day moving average price of $16.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.Sotera Health’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. On average, equities research analysts expect that Sotera Health Company will post 0.61 EPS for the current year.

Insider Buying and Selling

In other Sotera Health news, CEO Michael B. Jr. Petras sold 434,104 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $16.45, for a total value of $7,141,010.80. The sale was disclosed in a filing with the SEC, which is available through this link. In the last ninety days, insiders have sold 1,184,104 shares of company stock worth $19,478,511. Insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

Several large investors have recently bought and sold shares of the business. Sculptor Capital LP lifted its holdings in Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock worth $370,440,000 after buying an additional 7,658,200 shares during the last quarter. Sachem Head Capital Management LP raised its position in shares of Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after acquiring an additional 3,735,000 shares in the last quarter. Vanguard Group Inc. lifted its stake in Sotera Health by 16.7% during the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Sotera Health by 1,206.2% in the fourth quarter. AQR Capital Management LLC now owns 2,864,106 shares of the company’s stock valued at $50,523,000 after purchasing an additional 2,644,831 shares in the last quarter. Finally, Norges Bank purchased a new position in Sotera Health in the fourth quarter valued at approximately $45,278,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.